Evidence map›Paper›PMID 32737773›Full record

ArticleMolecular and cellular biochemistry2020

Effect of methoxy stilbenes-analogs of resveratrol-on the viability and induction of cell cycle arrest and apoptosis in human myeloid leukemia cells.

Małgorzata Zielińska-Przyjemska, Mariusz Kaczmarek, Violetta Krajka-Kuźniak, Marcin Wierzchowski, Wanda Baer-Dubowska

Open access · hybridAbstract read
In one paragraph

Article in Molecular and cellular biochemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Małgorzata Zielińska-PrzyjemskaDepartment of Pharmaceutical Biochemistry, Poznan University of Medical Sciences, Poznan, Poland. mzielin@ump.edu.pl.ORCID http://orcid.org/0000-0002-3821-9759
Mariusz KaczmarekDepartment of Clinical Immunology, Poznan University of Medical Sciences, Poznan, Poland.
Violetta Krajka-KuźniakDepartment of Pharmaceutical Biochemistry, Poznan University of Medical Sciences, Poznan, Poland.
Marcin WierzchowskiDepartment of Chemical Technology of Drugs, Poznan University of Medical Sciences, Poznan, Poland.
Wanda Baer-DubowskaDepartment of Pharmaceutical Biochemistry, Poznan University of Medical Sciences, Poznan, Poland.
Poznan University of Medical Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study aimed to evaluate the cytotoxicity and its mechanism of five synthetic methoxy stilbenes, namely 3,4,4'-trimethoxy, 3,4,2'-trimethoxy, 3,4,2',4'-tetramethoxy, 3,4,2',6'-tetramethoxy, and 3,4,2',4',6'-pentamethoxy-trans-stilbenes (MS), in comparison with resveratrol (RSV). Human promyelocytic (HL-60) and monocytic leukemia (THP-1) cells were treated with the tested compounds for 24 h, and cytotoxicity, cell cycle distribution, and apoptosis were evaluated. Significant differences were found in the susceptibility of these cell lines to all stilbenes, including RSV. The THP-1 cells were more resistant to cytotoxic activity of these compounds than HL-60 cells. Among the tested stilbenes, 3,4,4'-tri-MS and 3,4,2',4'-tetra-MS exhibited higher cytotoxicity toward both cell lines than RSV and the other methoxy stilbenes. This activity might be related to cell cycle arrest at the G2/M phase and induction of apoptosis. In this regard, 3,4,4'-tri-MS and 3,4,2',4'-tetra-MS at highest concentrations increased the p53 protein level particularly in HL-60 cells. Moreover, treatment with these derivatives increased the ratio of the proapoptotic Bax protein to the antiapoptotic Bcl-xl protein, suggesting the induction of apoptosis through the intrinsic mitochondrial pathway in both cell lines. Further studies are required to fully elucidate the mechanism of these activities.

Indexed as

ApoptosisCell Cycle CheckpointsAntioxidantsbcl-2-Associated X Proteinbcl-X ProteinCell SurvivalGene Expression Regulation, NeoplasticHL-60 CellsHumansLeukemia, MyeloidResveratrolStilbenesTumor Suppressor Protein p53AntioxidantsBAX protein, humanbcl-2-Associated X ProteinBCL2L1 protein, humanbcl-X ProteinResveratrolStilbenesTP53 protein, humanTumor Suppressor Protein p53ApoptosisMethoxy stilbenesMonocytic leukemia cellsPromyelocytic leukemia cellsResveratrol

Identifiers

PMID32737773
PMCPMC7524858
OpenAlexW3046515538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.